Assembly Biosciences - 9 Year Stock Split History | ASMB

Stock split history for Assembly Biosciences since 2010. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Assembly Biosciences Annual Stock Splits
Assembly Biosciences Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.423B $0.015B
Assembly Biosciences, Inc. is a biopharmaceutical company. It develops therapies for infectious diseases and other disorders of the gastrointestinal (GI) system. Assembly's product portfolio consists of two late stage assets: VEN 307 for relief from pain associated with anal fissures and VEN 308 for the treatment of fecal incontinence. The Company is also developing novel microbiome-based technology for targeted oral delivery of therapeutic bacteria, complex proteins, viral antigens and small molecules to treat intractable infectious diseases of the GI tract, such as C. difficile infections. Assembly Biosciences Inc., formerly known as Ventrus Biosciences, Inc., is based in New York.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $46.669B 8.40
Teva Pharmaceutical Industries (TEVA) Israel $14.602B 5.04
Mylan (MYL) United Kingdom $13.853B 5.86
Bausch Health Cos (BHC) Canada $8.091B 5.75
Dr Reddy's Laboratories (RDY) India $6.770B 27.00
Supernus Pharmaceuticals (SUPN) United States $1.887B 17.51
Mallinckrodt Public Limited Company (MNK) United Kingdom $1.523B 2.47
Amphastar Pharmaceuticals (AMPH) United States $0.943B 87.65
Homology Medicines (FIXX) United States $0.832B 0.00
CymaBay Therapeutics (CBAY) United States $0.718B 0.00
Voyager Therapeutics (VYGR) United States $0.626B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.410B 0.00
Akorn (AKRX) United States $0.348B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.172B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.170B 0.00
Sol-Gel Technologies (SLGL) Israel $0.132B 0.00
Acasti Pharma (ACST) Canada $0.074B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.061B 0.00
Agile Therapeutics (AGRX) United States $0.060B 0.00
Teligent (TLGT) United States $0.044B 0.00
Aevi Genomic Medicine (GNMX) United States $0.014B 0.00
Evoke Pharma (EVOK) United States $0.013B 0.00